Invest with Confidence
Investors select the cases they want to back from our pre-vetted list of projects.
Litigation Finance
Trimaxian’s investor syndicate allows accredited investors and family offices to choose which types of litigation they want to financially back after careful review by the Trimaxian team.
Finance & Risk Management
Mass action litigation is uncorrelated with market fluctuations. Trimaxian offers the potential for significantly higher yields with lower risk, stricter quality control, and lower barrier to entry.
Our Investor Syndicate
Our investors can diversify their portfolio across multiple cases. Our legal and marketing teams work with top-tier litigation firms to ensure our offerings include only the most promising cases.
Invest with Confidence
Building Resilient Financial Strategies for the Future
$15.2
Billion Industry Value
400%
Historical Average ROI
18
Months Average Return Time
Proven Returns,
Trusted & Secure
Over the past several years, mass tort litigation has resulted in numerous substantial settlements, highlighting the significant financial opportunities within this sector. These cases underscore the potential for rewarding investments in mass tort actions.
- 2020 – Bayer, $10b Settlement
- 2016 – Wright Medical Technology, $240m Settlement
- 2010 – British Petroleum, $20b Settlement
Defective Products
These involve dangerous or defective products that cause widespread harm. Examples include pharmaceuticals, medical devices, and consumer products.
Learn MoreToxic Torts
These arise from exposure to harmful substances in the environment or workplace. Examples include water contamination, and exposure to hazardous chemicals.
Learn MoreConsumer Fraud
These involve deceptive business practices, fraud, or financial misconduct affecting large groups of consumers, such as data breaches and deceptive marketing.
Learn MoreDisaster-related Torts
These are catastrophic events caused by negligence, leading to widespread damages. Examples include wildfires, oil spills, and environmental disasters.
Learn MoreBlog & News
Stay on top of the latest Litigation Finance News with Trimaxian
2025 in Review: The Shift Toward ABS-Backed Litigation Finance As 2025 draws to a close, the landscape of alternative investments... Read More ›
As sophisticated investors consider diversifying their portfolios beyond traditional stocks and bonds, they often find themselves navigating complex regulatory and... Read More ›
At Trimaxian, we believe in transparency—in our structure, our partners, and our approach to litigation‑investment opportunities. That includes being very... Read More ›